statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Moderna, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of...

Looking Into Regeneron Pharmaceuticals's Recent Short Interest

Kuehn Law Encourages Investors of Regeneron Pharmaceuticals, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Regeneron Pharmaceuticals, Inc. to Contact Law Firm Kuehn Law Encourages Investors of Regeneron Pharmaceuticals, Inc. to Contact Law Firm PR Newswire NEW YORK, July...

The Analyst Verdict: Regeneron Pharmaceuticals In The Eyes Of 13 Experts

Latest Ratings for REGN
 DateFirmActionFromTo Feb 2022Truist SecuritiesMaintainsBuy Feb 2022OppenheimerMaintainsOutperform Feb 2022Morgan StanleyMaintainsEqual-Weight
 View More Analyst Ratings...

Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments

Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments PR Newswire...

Peering Into Regeneron Pharmaceuticals's Recent Short Interest

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Volume	380,897.00
52-Wk High	$1,106.16
52-Wk Low	$723.56

REGN Regeneron Pharmaceuticals, Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals